CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Goldman Sachs Initiates Coverage on Abivax With Buy Rating, $155 Price Target

Positive
AI Analysis

Summary

Goldman Sachs initiated coverage on Abivax with a Buy rating and $155 price target.

Importance:3/10
Sentiment:
0.70
analyst_coverageprice_targetbuy_rating
Related Companies

Read the original article

Published by yahoo_finance on September 10, 2026 11:19 AM

Read Original